Fundraising FoxKiji TX
1 known investors
Find your way into Kiji TX
Sign up to see every warm intro you have to Kiji TX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kiji TX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
KIJI Tx develops gene-engineered iPSC-derived MSC cell therapies for treating a broad range of inflammatory diseases, with a lead product using IL10 and CXCR4 transduction. The company works in collaboration with research institutions including CIBER, Fundación Jiménez Díaz, and CIEMAT.
Founders & leadership
JB
Juan BuerenScientific Founder
RY
Rosa YanezScientific Founder
MF
Maria FernandezScientific Founder; Product Manager
BD
Begona DiezScientific Founder
ML
Mercedes LopezScientific Founder
MF
Miguel ForteCEOMiguel Forte holds an MD and PhD and brings over three decades of experience across clinical, academic, regulatory, and pharmaceutical industry roles, including operational and strategic leadership in R&D, manufacturing, regulatory, medical, and general management.
TT
Tony TingCSO
MA
Michel AndraudCFO
YW
Yen WuCBO
Investors · 1
Frequently asked questions
- What does Kiji TX do?
- KIJI Tx develops gene-engineered iPSC-derived MSC cell therapies for treating a broad range of inflammatory diseases, with a lead product using IL10 and CXCR4 transduction. The company works in collaboration with research institutions including CIBER, Fundación Jiménez Díaz, and CIEMAT.
- Who founded Kiji TX?
- Kiji TX was founded by Juan Bueren, Rosa Yanez, Maria Fernandez, Begona Diez, Mercedes Lopez.
- Who are Kiji TX's investors?
- Kiji TX's investors include AdBio partners.